AI-powered pathology for drug development
PathAI uses machine learning to improve the accuracy of pathology diagnoses and accelerate the development of new therapies. Their platform analyzes tissue slides to identify biomarkers and disease patterns that may be missed by the human eye. PathAI partners with pharmaceutical companies to help them design more effective clinical trials and identify the patients most likely to benefit from new treatments. It is a crucial tool for the future of precision medicine and oncology.